NFE2L2 and Sepsis: Collectively, these findings suggest that mollugin has a dual effect on reducing sepsis by attenuating TAK1-mediated NF-κB/MAPK signaling and promotes the activation of the Nrf2 pathway, suggesting that it may be an ideal therapeutic candidate for treating sepsis [39].